News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,971 Results
Type
Article (17603)
Company Profile (286)
Press Release (316082)
Multimedia
Podcasts (49)
Webinars (8)
Section
Business (96843)
Career Advice (178)
Deals (16988)
Drug Delivery (40)
Drug Development (56152)
Employer Resources (35)
FDA (8063)
Job Trends (6088)
News (175458)
Policy (13401)
Tag
Academia (1078)
Accelerated approval (2)
Adcomms (12)
Allergies (58)
Alliances (27549)
ALS (66)
Alzheimer's disease (944)
Antibody-drug conjugate (ADC) (104)
Approvals (8109)
Artificial intelligence (147)
Autoimmune disease (19)
Automation (5)
Bankruptcy (122)
Best Places to Work (5243)
BIOSECURE Act (6)
Biosimilars (54)
Biotechnology (237)
Bladder cancer (62)
Brain cancer (20)
Breast cancer (172)
Cancer (1585)
Cardiovascular disease (185)
Career advice (159)
Career pathing (2)
CAR-T (118)
Cell therapy (341)
Cervical cancer (8)
Clinical research (46049)
Collaboration (591)
Compensation (289)
Complete response letters (14)
COVID-19 (1178)
CRISPR (42)
C-suite (178)
Cystic fibrosis (76)
Data (1680)
Denatured (11)
Depression (33)
Diabetes (171)
Diagnostics (1987)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (90)
Drug pricing (38)
Drug shortages (7)
Duchenne muscular dystrophy (91)
Earnings (36176)
Editorial (18)
Employer branding (5)
Employer resources (33)
Events (55459)
Executive appointments (506)
FDA (8897)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (537)
Gene editing (98)
Generative AI (10)
Gene therapy (269)
GLP-1 (486)
Government (1337)
Grass and pollen (3)
Guidances (36)
Healthcare (7790)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (95)
Indications (22)
Infectious disease (1252)
Inflammatory bowel disease (121)
Inflation Reduction Act (8)
Influenza (26)
Intellectual property (76)
Interviews (19)
IPO (8399)
IRA (15)
Job creations (1168)
Job search strategy (152)
Kidney cancer (7)
Labor market (5)
Layoffs (227)
Leadership (3)
Legal (2320)
Liver cancer (45)
Lung cancer (220)
Lymphoma (108)
Machine learning (4)
Management (8)
Manufacturing (162)
MASH (61)
Medical device (4500)
Medtech (4502)
Mergers & acquisitions (8974)
Metabolic disorders (481)
Multiple sclerosis (57)
NASH (15)
Neurodegenerative disease (71)
Neuropsychiatric disorders (25)
Neuroscience (1369)
NextGen: Class of 2025 (2279)
Non-profit (1057)
Now hiring (22)
Obesity (252)
Opinion (107)
Ovarian cancer (65)
Pain (48)
Pancreatic cancer (62)
Parkinson's disease (124)
Partnered (9)
Patents (143)
Patient recruitment (86)
Peanut (35)
People (29887)
Pharmaceutical (49)
Pharmacy benefit managers (5)
Phase I (15456)
Phase II (20854)
Phase III (14263)
Pipeline (905)
Policy (55)
Postmarket research (1297)
Preclinical (6542)
Press Release (32)
Prostate cancer (71)
Psychedelics (35)
Radiopharmaceuticals (222)
Rare diseases (301)
Real estate (2037)
Recruiting (14)
Regulatory (10998)
Reports (18)
Research institute (1086)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (11)
Schizophrenia (62)
Series A (103)
Series B (70)
Service/supplier (1)
Sickle cell disease (41)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (13)
Startups (2253)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (11)
The Weekly (37)
Vaccines (243)
Venture capitalists (33)
Weight loss (149)
Women's health (15)
Worklife (2)
Date
Today (61)
Last 7 days (565)
Last 30 days (1625)
Last 365 days (21428)
2025 (7060)
2024 (22713)
2023 (25043)
2022 (31850)
2021 (32767)
2020 (28108)
2019 (19852)
2018 (14542)
2017 (16745)
2016 (14951)
2015 (18151)
2014 (13622)
2013 (10337)
2012 (10626)
2011 (10940)
2010 (10617)
Location
Africa (211)
Alabama (42)
Alaska (2)
Arizona (64)
Arkansas (5)
Asia (30942)
Australia (4604)
California (4109)
Canada (1298)
China (435)
Colorado (155)
Connecticut (156)
Delaware (116)
Europe (48319)
Florida (519)
Georgia (123)
Idaho (16)
Illinois (260)
India (15)
Indiana (107)
Iowa (2)
Japan (133)
Kansas (69)
Kentucky (6)
Louisiana (3)
Maine (13)
Maryland (532)
Massachusetts (3308)
Michigan (75)
Minnesota (201)
Mississippi (1)
Missouri (29)
Montana (14)
Nebraska (4)
Nevada (21)
New Hampshire (15)
New Jersey (1138)
New Mexico (13)
New York (1153)
North Carolina (630)
North Dakota (5)
Northern California (1816)
Ohio (119)
Oklahoma (9)
Oregon (22)
Pennsylvania (774)
Puerto Rico (6)
Rhode Island (19)
South America (313)
South Carolina (7)
Southern California (1573)
Tennessee (35)
Texas (476)
United States (14472)
Utah (64)
Virginia (83)
Washington D.C. (33)
Washington State (366)
West Virginia (1)
Wisconsin (19)
333,971 Results for "nanoform cardiovascular therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in development to date” in the competitive Lp(a) space, where drugs are designed to lower the risk of cardiovascular events such as heart attack and stroke.
March 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Atherosclerotic Cardiovascular Disease Market Size to Reach USD 30.6 Billion by 2035, Impelled by Advancements in Novel Drug Therapies
Atherosclerotic Cardiovascular Disease Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Cardiovascular disease
Deep Dive: Cardiovascular Disease Back in the Spotlight
In this deep dive,
BioSpace
explores the diverse therapeutic modalities now in development, as well as the opportunities and battles for market dominance in this emerging space.
March 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio
May 2, 2025
·
6 min read
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Press Releases
Semaglutide 2.4 mg reduces burden of total cardiovascular events in people with established cardiovascular disease and overweight or obesity
March 31, 2025
·
9 min read
1 of 33,398
Next
